Lixte Biotechnology (LIXT) Stock Price, Quote, News & History

Q: What sector and industry does Lixte Biotechnology (LIXT) operate in?

Lixte Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Lixte Biotechnology Holdings Inc (LIXT) Stock Price, Quote, News & History

LIXTNASDAQ

Trade with Public

$2.98

0.031.02%

At close: Feb 9, 4:00 PM EST

$3.05

0.072.35%

After Hours: 9:28 AM EST

Key Statistics

Open

$3.02

$2.98

Volume / Avg.

111.49K / 91.01K

Day Range

$2.76 - $3.05

52 Wk Range

0.64 - 6.26

Market Cap

$24.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.36%

Days to Cover

1.3

Recent Lixte Biotechnology Holdings Inc News

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates

Avi Kapoor

Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.58M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

6.47M

Free Cash Flow (TTM)

-2.58M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

1.25M

Valuation Metrics

Enterprise Value

$23.06M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

10.96

Earnings Yield % (TTM)

-40.07%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.27

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.89M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$3.02

$2.98

Volume / Avg.

111.49K / 91.01K

Day Range

$2.76 - $3.05

52 Wk Range

0.64 - 6.26

Market Cap

$24.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.36%

Days to Cover

1.3

About

Sector

Health Care

Industry

Biotechnology

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lixte Biotechnology (LIXT) stock?

You can purchase shares of Lixte Biotechnology (NASDAQ:LIXT) through any online brokerage.

View our list of the best stock brokerages

Who are Lixte Biotechnology (LIXT) competitors?

Other companies in Lixte Biotechnology’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), Intensity Therapeutics Inc (NASDAQ:INTS), Nanoviricides Inc (AMEX:NNVC) and Lunai Bioworks Inc (NASDAQ:LNAI).

What is the forecast, or price target, for Lixte Biotechnology (LIXT) stock?

There is no analysis for Lixte Biotechnology to provide a consensus price target.

What is the current price for Lixte Biotechnology (LIXT)?

The stock price for Lixte Biotechnology (NASDAQ: LIXT) is $3.05 last updated February 9, 2026 at 9:28 AM EST.

Does Lixte Biotechnology (LIXT) pay a dividend?

There are no upcoming dividends for Lixte Biotechnology.

When is Lixte Biotechnology (NASDAQ:LIXT) reporting earnings?

Lixte Biotechnology does not have any upcoming earnings scheduled.

Is Lixte Biotechnology (LIXT) going to split?

There is no upcoming split for Lixte Biotechnology.

What sector and industry does Lixte Biotechnology (LIXT) operate in?

Lixte Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

SER

Intensity Therapeutics Inc

NNVC

Palatin Technologies Inc

AMEX:PTN

$16.65

5.92%

Vistagen Therapeutics Inc

NASDAQ:VTGN

$0.55

-2.11%

APUS

Key Statistics

Open

$3.02

$2.98

Volume / Avg.

111.49K / 91.01K

Day Range

$2.76 - $3.05

52 Wk Range

0.64 - 6.26

Market Cap

$24.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.36%

Days to Cover

1.3

Recent Lixte Biotechnology Holdings Inc News

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates

Avi Kapoor

Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.58M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

6.47M

Free Cash Flow (TTM)

-2.58M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

1.25M

Valuation Metrics

Enterprise Value

$23.06M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

10.96

Earnings Yield % (TTM)

-40.07%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.27

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.89M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$3.02

$2.98

Volume / Avg.

111.49K / 91.01K

Day Range

$2.76 - $3.05

52 Wk Range

0.64 - 6.26

Market Cap

$24.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.36%

Days to Cover

1.3

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry